Computerized Cognitive Training in Healthy Older Adults and Mild Cognitive Impairment
The overall objective of this study is to assess the effect of an adaptive computerized cognitive training program for executive functions (CogniFit platform) on improving these functions in older adults, both healthy and with mild cognitive impairment (MCI), as well as to examine the potential transfer effects of this
| Condition(s) | Mild Cognitive Impairment (MCI), Healthy Aging |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The overall objective of this study is to assess the effect of an adaptive computerized cognitive training program for executive functions (CogniFit platform) on improving these functions in older adults, both healthy and with mild cognitive impairment (MCI), as well as to examine the potential transfer effects of this training on memory. Additionally, determine the impact of the intervention on the emotional symptoms, behavioral disorders, or quality of life of the participants. |
| Who can participate | Inclusion Criteria: 1. adults 65 years of age and older; 2. spanish speakers; 3. residents in Spain (urban and rural communities); 4. elderly population that does not have dementia or other major diagnosed uncontrolled neurological disorders; 5. the initial cognitive state will be determined by a global screening test, the Lobo's Mini Cognitive Examination, that is, the spanish version of the Mini-Mental State Examination (MMSE); and 6) all participants must provide their signed written informed consent indicating that the individual has been informed of the relevant aspects of the study (and may withdraw from the study at any time if they so request). Exclusion Criteria: 1. Older adults who obtain scores indicative of severe impairment (to be determined for low MEC scores that are suggest |
| Ages | 65 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Universidad Antonio de Nebrija |
| Locations | Madrid, Madrid, Spain; Madrid, Madrid, Spain |
| Start date | 2025-06-04 |
| NCT ID | NCT07598409 |
| Official listing | https://clinicaltrials.gov/study/NCT07598409 |